CTXR Bull Call Spread Strategy
CTXR (Citius Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS).
CTXR (Citius Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.0M, a beta of 0.98 versus the broader market, a 52-week range of 0.476-2.48, average daily share volume of 663K, a public-listing history dating back to 2014, approximately 23 full-time employees. These structural characteristics shape how CTXR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.98 places CTXR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a bull call spread on CTXR?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
Current CTXR snapshot
As of June 30, 2026, spot at $0.60, ATM IV 17.50%, IV rank 0.00%, expected move 5.02%. The bull call spread on CTXR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this bull call spread structure on CTXR specifically: CTXR IV at 17.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a CTXR bull call spread, with a market-implied 1-standard-deviation move of approximately 5.02% (roughly $0.03 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CTXR expiries trade a higher absolute premium for lower per-day decay. Position sizing on CTXR should anchor to the underlying notional of $0.60 per share and to the trader's directional view on CTXR stock.
CTXR bull call spread setup
The CTXR bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CTXR near $0.60, the first option leg uses a $0.60 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CTXR chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CTXR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.60 | N/A |
| Sell 1 | Call | $0.63 | N/A |
CTXR bull call spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
CTXR bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on CTXR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bull call spread on CTXR
Bull call spreads on CTXR reduce the cost of a bullish CTXR stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
CTXR thesis for this bull call spread
The market-implied 1-standard-deviation range for CTXR extends from approximately $0.57 on the downside to $0.63 on the upside. A CTXR bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on CTXR, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current CTXR IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CTXR at 17.50%. As a Healthcare name, CTXR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CTXR-specific events.
CTXR bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CTXR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CTXR alongside the broader basket even when CTXR-specific fundamentals are unchanged. Long-premium structures like a bull call spread on CTXR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CTXR chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on CTXR?
- A bull call spread on CTXR is the bull call spread strategy applied to CTXR (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With CTXR stock trading near $0.60, the strikes shown on this page are snapped to the nearest listed CTXR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CTXR bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the CTXR bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 17.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CTXR bull call spread?
- The breakeven for the CTXR bull call spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CTXR market-implied 1-standard-deviation expected move is approximately 5.02%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on CTXR?
- Bull call spreads on CTXR reduce the cost of a bullish CTXR stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current CTXR implied volatility affect this bull call spread?
- CTXR ATM IV is at 17.50% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.